A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT05767021 · COMPLETED
Trial details
- NCT number
- NCT05767021
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-17
- Primary completion
- 2024-08-09
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.